BS Bhati

C Gan

C Schmitz

CA Pedra

CA Warnes

Cheng Zhang

D Milkovic

DJ Waight

E Cardis

EA Bacha

F Li

GE Sarris

J Yang

JF Zhao

K Ak

L Ait-Ali

L Hongxin

LB Signorello

M Argenziano

MG Andreassi

Nicola Vistarini

P Ewert

Q Chen

Q Xing

Qing-kui Guo

R Fazel

R Malhotra

S Abadir

SH Jung

Shao-fei Cheng

SQ Yu

VE Hjortdal

X Quansheng

XJ Zeng

Y Kikuchi

YC Fu

YJ Woo

Yong Cao

Yong-hong Zhao

Yue-li Zhang

Z Amin

Zhi-qian Lu

Journal of Cardiothoracic Surgery

English

PubMed

Springer - Publisher Connector

Off-pump occlusion of trans-thoracic minimal invasive surgery (OPOTTMIS) on simple congenital heart diseases (ASD, VSD and PDA) attached consecutive 210 cases report: A single institute experience

Abstract
          
            Objective
            This paper intends to report our experiences by using an operation of off-pump occlusion of trans-thoracic minimal invasive surgery (OPOTTMIS) on the treatment of consecutive 210 patients with simple congenital heart diseases (CHD) including atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA).
          
          
            Methods
            The retrospective clinical data of OPOTTMIS in our institute were collected and compared to other therapeutic measures adopted in the relevant literatures. After operation, all the patients received electrocardiography (ECG) and echocardiography (echo) once a month within the initial 3 months, and no less than once every 3 ~ 6 months later.
          
          
            Results
            The successful rate of the performed OPOTTMIS operation was 99.5%, the mortality and complication incidence within 72 hours were 0.5% and 4.8%, respectively. There were no major complications during peri-operation such as cardiac rupture, infective endocarditis, strokes, haemolysis and thrombosis. The post-operation follow-up outcomes by ECG and echo checks of 3 months to 5 years showed that there were no III° AVB, no obvious Occluder migration and device broken and no moderate cardiac valve regurgitation, except 1 VSD and 1 PDA with mild residual shunts, and 2 PDA with heart expansion after operation. However, all the patients' heart functions were in class I~II according to NYH standard.
          
          
            Conclusion
            The OPOTTMIS is a safe, less complex, feasible and effective choice to selected simple CHD patients with some good advantages and favorable short term efficacies.
          </jats:sec

Crossref

A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects [J]. Catheter Cardiovasc Interv

A New Minimally Invasive Technique to Occlude Ventricular Septal Defect Using an Occluder Device. Ann Thorac Surg

al: Device closure of perimembranous ventricular septal defects with a minimally invasive technique in 12 patients [J]. Ann Thorac Surg

al: Hybrid approaches to complex congenital cardiac surgery [J]. Eur J Cardiothoracic Surg

al: Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: preliminary results with the perventricular technique [J]. J Thorac Cardiovasc Surg

al: Intraoperative device closure of secundum atrial septal defect with a right anterior minithoracotomy in 100 patients [J]. J Thorac Cardiovasc Surg

al: Minimally invasive atrial septal defects repair [J]. Indian Heart J

al: Multicenter Experience with Perventricular Device Closure of Muscular Ventricular Septal Defects [J]. Pediatr Cardiol

al: Perventricular device closure of congenital muscular ventricular septal defects [J]. Expert Rev Cardiovasc Ther

al: Robotically assisted perventricular closure of perimembranous ventricular septal defects: preliminary results in Yucatan pigs [J]. J Thorac Cardiovasc Surg

al: Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association [J]. Eur J Cardiothorac Surg

al: Totally endoscopic closure of an atrial septal defect using the da Vinci Surgical System: report of four cases [J]. Surg Today

An Q, et al: Ventricular device closure of muscular ventricular septal defects on beating hearts: Initial experience in eight children [J]. J Thorac Cardiovasc Surg

Cardiac catheterization and longterm chromosomal damage in children with congenital heart disease [J]. Eur Heart J

et al: Advances in paediatric interventional cardiology since

et al: Closure of atrial septal defect with occluder by minimally invasive and non- extracorporeal circulation ways [J].

et al: Closure of patent ductus arteriosus during open-heart surgery: Surgical experience with different techniques [J]. J Thorac Cardiovasc Surg

et al: Cumulative patient effective dose and acute radiation-induced chromosomal DNA damage in children with congenital heart disease. Heart

et al: Minimally invasive perventricular device closure of an isolated perimembranous ventricular septal defect with a newly designed delivery system: Preliminary experience. J Thorac Cardiovasc Surg

et al: Minimally invasive perventricular device closure of perimembranous ventricular septal defect without cardiopulmonary bypass: Multicenter experience and mid-term followup. J Thorac Cardiovasc Surg

et al: Port-access minimally invasive surgery for atrial septal defects: A 10-year singlecenter experience in 166 patients. J Thorac Cardiovasc Surg

et al: Primary DNA damage assessed with the comet assay and comparison to the absorbed dose of diagnostic X-rays in children [J].

et al: Totally endoscopic atrial septal defect repair with robotic assistance [J]. Heart Surg Forum

et al: Transcatheter closure of atrial septal defects under echocardiographic guidance without X-ray: initial experiences [J]. Cardiol Young

et al: Transcatheter closure of perimembranous ventricular septal defects using the new amplatzer membranous VSD occluder: results of the U.S. phase I trial [J].

Evolution of surgical techniques for atrial septal defect repair in adults: a 10-year singleinstitution experience [J]. J Thorac Cardiovasc Surg

Exposure to low-doseionizing radiation from medical imaging procedures [J].

GQ: Advances in congenjtal heart disease catheter closure [J]. Adv Cardiovasc dis

Guidelines for the Management of Adults With Congenital Heart Disease [J]. JACC

Hijazi ZM: Closure of muscular ventricular septal defects: Transcatheter and hybrid techniques [J]. Catheter Cardiovasc Interv

Hijazi ZM: Pediatric cardjology: the cardiologist’s role and relationship with pediatric cardiothoracic surgery [J]. Adv Cardiol Surg

Hybrid procedures can reduce the risk of congenital cardiovascular surgery [J]. Eur J Cardiothoracic Surg

Intraoperative Device Closure of Doubly Committed Subarterial Ventricular Septal Defects: Initial Experience [J]. Ann Thorac Surg

Right or left anterolateral minithoracotomy for repair of congenital ventricular septal defects in adult patient [J]. Interact Cardiovasc Thorac Surg

Robotic cardiac surgery [J].

The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks [J]. Radiat Res

Transcatheter device closure of perimembranous ventricular septal defects: mid-term outcomes [J]. European Heart Journal

file:///data/remote/core/dit/data/Springer-OA/pdf/617/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvMTc0OS04MDkwLTYtNDgucGRm.pdf

Off-pump occlusion of trans-thoracic minimal invasive surgery (OPOTTMIS) on simple congenital heart diseases (ASD, VSD and PDA) attached consecutive 210 cases report: A single institute experience

Abstract

Similar works

Full text

Available Versions

Springer - Publisher Connector

Crossref